Ginkgo Bioworks shares jump 10.22% intraday after expanding service offerings and enhancing R&D efficiency with Autonomous Lab and AI/ML platform.
ByAinvest
Tuesday, Mar 31, 2026 10:37 am ET1min read
DNA--
Ginkgo Bioworks surged 10.22% intraday as the company disclosed in its 2025 annual report that its two core businesses are providing bio R&D tools and services for cell engineering and offering biosecurity solutions for government and commercial clients through biological threat monitoring and protection services. The report also noted that in 2024, the company expanded its service offerings to include tools allowing clients to conduct certain bio R&D independently, while leveraging its Autonomous Lab and AI/ML platform to enhance success rates, speed, and cost efficiency in R&D.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet